The anti-tumor activities of the extracts of Ganoderma lucidum
Shujuan LI,Hongbi LIU,Xiaoyun LI,Nan HU,Xu BAO,Hong WANG
DOI: https://doi.org/10.13375/j.cnki.wcjps.2018.02.018
2018-01-01
Abstract:OBJECTIVE To explore the anti-tumor activities of the ethanol extracts of Ganoderrna lucidum(EEGL) in vitro and in vivo.METHODS Six human cancer cell lines including epidermoid cancer cells A431,stomach cancer cells BGC823,colorectal cancer cells Caco2,ovarian cancer cells ES-2,lung cancer cells NCI-H460 and colon cancer cells SW620 were treated with EEGL.The anti-tumor activities of EEGL was investigated with cellular morphology,growth curve,MTF assay and Colony-forming experiments.We established BGC823 stomach cancer nude mouse transplantation tumor model and treated with EEGL at the dose of 50,100 and 150 mg·kg-1 respectively,then the tumors' size,inhibitory rate and viscera coefficient were calculated.RESULTS In vitro experiment,the IC50 of EEGL on epidermoid cancer cells A431,stomach cancer cells BGC823,colorectal cancer cells Caco2,ovarian cancer cells ES-2,lung cancer cells NCI-H460 and colon cancer cells SW620 were 85.86,193.43,51.32,168.72,82.61,212.98 μg·mL-1respectively determined by MTT assay.In vivo experiment,the tumor inhibition rates of 50,100,150 mg· kg-1 dose were 32.6％,43.5％ and 47.2％,respectively.CONCLUSION In vitro results imply that EEGL has inhibitory effect on epidermal cancer A431,rectal cancer Caco 2 and lung cancer NCI-H460.The inhibitory effect is obvious when the concentration was above 40 μg·ml-1.In vivo experiments indicate that EEGL can inhibit the growth of stomach cancer BGC823.